## EXPD: Expeditors International of Washington, Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 -1.1% below STRENGTH zone (3.0-6.0%); PEG 5.28 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($145.01)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 5
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Navigating the Global Grid: An In-Depth Analysis of Expeditors International (EXPD) in 2025**
- Source: FinancialContent | 20251229T100800 | Somewhat-Bullish | Relevance: 100%
- This article provides a detailed analysis of Expeditors International (EXPD) in 2025, highlighting its resilience amidst geopolitical tensions and technological shifts. It covers the company's asset-light business model, strong financial performance, leadership transition, and innovative technologies like Cargo Signal and EXP.O NOW. The report also discusses EXPD's competitive landscape, industry trends, risks, opportunities, and investor sentiment.

**2. Navigating the Global Grid: An In-Depth Analysis of Expeditors International (EXPD) in 2025**
- Source: FinancialContent | 20251229T100800 | Somewhat-Bullish | Relevance: 100%
- This article provides a comprehensive analysis of Expeditors International (EXPD) in 2025, detailing its resilience amidst geopolitical tensions and technological shifts. It covers the company's asset-light business model, strong financial performance, recent leadership transition, and innovative services like Cargo Signal. Despite market risks from China exposure and cybersecurity, EXPD's zero-debt balance sheet and consistent shareholder returns position it as a robust player in the volatile logistics sector.

**3. Here's Why Investors Should Bet on Wabtec Stock Right Now**
- Source: Finviz | 20251230T180820 | Somewhat-Bullish | Relevance: 86%
- Wabtec (WAB) is highlighted as a strong investment due to robust backlog growth and shareholder-friendly initiatives, leading to impressive stock performance. The company has seen upward earnings estimate revisions, solid price performance, and positive earnings surprises. Additionally, WAB boasts a desirable Zacks Rank #2 (Buy) and is part of a bullish industry group, indicating continued growth potential.

**4. C.H. Robinson Surges 71.6% in 6 Months: What Should Investors Do Now?**
- Source: Finviz | 20251229T200739 | Somewhat-Bullish | Relevance: 74%
- C.H. Robinson Worldwide, Inc. (CHRW) has seen a significant 71.6% surge in its stock over the last six months, outperforming its industry and competitors. Despite this impressive rally and CHRW's consistent shareholder-friendly initiatives and attractive valuation, investors are advised against buying due to weak freight demand and a concerning liquidity position. Current shareholders are encouraged to retain their investment, as the company holds a Zacks Rank #3 (Hold).

**5. C.H. Robinson Surges 71.6% in 6 Months: What Should Investors Do Now?**
- Source: TradingView â€” Track All Markets | 20251229T190744 | Neutral | Relevance: 65%
- C.H. Robinson Worldwide, Inc. (CHRW) stock has seen a significant 71.6% surge over the last six months, outperforming its industry peers. This performance is attributed to consistent dividend payments, share buybacks, and decreased operating expenses. However, headwinds such as weak freight demand and a concerning liquidity position currently make it a "Hold" according to Zacks Rank, suggesting investors already holding the stock should retain it, but new investors wait for a better entry point.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-16 | Stifel | $136 | $130 | +5% |
| 2025-12-08 | Morgan Stanley | $95 | $90 | +6% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-16 | Stifel | main | Hold |
| 2025-12-08 | Morgan Stanley | main | Underweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 8 ($0.01M) |
| Sells | 2 ($0.93M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 12.5% (-0.9%)
- Blackrock Inc.: 9.2% (-10.1%)
- State Street Corpora: 5.8% (+5.1%)
- First Eagle Investme: 4.7% (+0.0%)
- LOOMIS SAYLES & CO L: 4.3% (+1.6%)

### Key Risks

1. Valuation stretched: PEG 5.3x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 5.28 signals overvaluation risk, limited margin of safety. Forward P/E 25.2x stretched relative to 2% growth. Quality metrics strong (ROE 36%, ROA 14%). Analyst sentiment positive (2 raises, avg +5%). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $20.4B |
| Beta | 1.14 |
| 52W Range | $100.47 - $155.04 |
| Short Interest | 4.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 5.28 |
| Forward P/E | 25.2 |
| Current P/E | 25.6 |
| YoY Growth | 1.5% |
| EPS Direction | RISING |

### Technicals

MRS_10 stable at -1.1% (minimal 5-day change). Below STRENGTH zone by 4.2pp (needs >3.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.23x) but short-term weakness (below SMA20). MACD histogram bearish (-0.81), momentum weakening. RSI neutral at 57. OFD pattern: -SBL (Volatile).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -1.15% (CS: 26) | Neutral |
| RSI_14 | 57.3 | Neutral |
| MACD Histogram | -0.81 | Bearish |
| vs SMA20 | 0.997x | Below |
| vs SMA50 | 1.072x | Above |
| vs SMA200 | 1.231x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $150.21
- **Stop Loss:** $145.01 (3.5% risk)
- **Target:** $155.41 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 253
- **Position Value:** $38,003.13
- **Portfolio %:** 38.00%
- **Risk Dollars:** $1,320.00
- **Risk Per Trade:** 1.32%
- **Modifiers:** L1 110% | L2 120% | Combined 1.32x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.10x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with balanced risk signals and moderate market participation. VIX at 14.33 indicates calm conditions, while positive yield curve (+59bps) and stable economic data support continued expansion. Year-end positioning and Fed uncertainty create near-term caution, but no systemic risks evident.*

### Earnings

**Next:** 2026-02-24 (Est: $1.43)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.39 | $1.64 | +18.1% |
| 2025Q2 | $1.24 | $1.34 | +7.9% |
| 2025Q1 | $1.35 | $1.47 | +9.1% |
| 2024Q4 | $1.44 | $1.68 | +16.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*